Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-05-02
1997-03-25
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
20415715, 20415762, 424 961, 514410, 540145, 607 2, 607 3, 607 61, 607 72, A61K 3170, C07C 600, A61N 100, A61N 700
Patent
active
056145020
ABSTRACT:
A method of treating diseases of cell proliferation in a patient such as neoplasms and rheumatoid arthritis including administering sub-toxic doses of a compound in combination with high pressure impulse transients. Methods are also provided for identifying compounds and impulse transient dosages useful for high pressure impulse transient chemotherapy.
REFERENCES:
patent: 4649151 (1987-03-01), Dougherty et al.
patent: 4656186 (1987-04-01), Bommer et al.
patent: 4658023 (1987-04-01), Shudo
patent: 4675338 (1987-06-01), Bommer et al.
patent: 4971991 (1990-11-01), Umemura et al.
patent: 4994014 (1991-02-01), Gordon
patent: 5380411 (1995-02-01), Schlief
Holmes et al., "Altered Neutrophil Permeability Following Shock Wave Exposure In Vitro", J. Urology, 147:733-737, 1992.
Berens et al., Effect of Acoustic Shock Waves on Clonogenic Growth and Drug Sensitivity of Human Tumor Cells In Vitro, J. Urology 142:1090-1094, 1989.
Holmes et al., The Combined Effects of Shock Waves and Cisplatin Therapy on Rat Prostate Tumors, J. Urology 144:159-163, 1990.
Randazzo et al., The in Vitro and in Vivo Effects of Extracorporeal Shock Waves on Malignant Cells, Urol. Res. 16:419-426,1988.
Russo et al., High Energy Shock Waves Suppress Tumor Growth In Vitro and In Vivo, J. Urol. 135:626-628, 1986.
Umemura et al., Mechanism of Cell Damage by Ultrasound in Combination with Hematoporphyrin, Jpn. J. Cancer Res. 81:962-966, 1990.
Vivino et al., Stable Cavitation at Low Ultrasonic Intensities Induces Cell Death and Inhibits .sup.3 H-TdR Incorporation by Con-A-Stimulated Murine Lymphocytes In Vitro, Ultrasound Med. Biol. II:751-759, 1985.
Yumita et al., Synergistic Effect of Ultrasound and Hematoporphyrin on Sarcoma 180, Jpn. J. Cancer Res. 81:304-308, 1990.
McCormack et al. Eur. J. Surg. Oncol., 19(3),pp. 232-234, (1993).
Oosterhof et al. Ultrasound Med Biol., 17(4), pp. 302-399, (1991).
Yumita et al. Jpn. J. Cancer Res., vol. 80, 219-222, (1989).
Anderson Therese M.
Doukas Apostolos
Flotte Thomas J.
McAuliffe Daniel J.
Kight John
Lee Howard C.
The General Hospital Corporation
LandOfFree
High-pressure impulse transient drug delivery for the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High-pressure impulse transient drug delivery for the treatment , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High-pressure impulse transient drug delivery for the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2203466